The best cutoff scores of the MoCA-Thai to discriminate aMCI from HC is ≤24 and from AD > 16.

The MoCA-Thai may be employed as a diagnostic criterion to make the diagnosis of aMCI, whereby aMCI patients are discriminated from HC with an area under the receiver-operating characteristic (AUC-ROC) curve of 0.813 and from AD patients with an AUC-ROC curve of 0.938. The MoCA-Thai shows adequate psychometric properties including internal consistency, concurrent validity, test-retest validity, and inter-rater reliability. This study included 60 HCs, 61 aMCI patients, and 60 AD patients. This study aimed to determine the reliability and validity of the following: (a) Thai translation of the MoCA (MoCA-Thai) and (b) delineate the key features of aMCI based on the MoCA subdomains. The Montreal Cognitive Assessment (MoCA) is an effective and applicable screening instrument to confirm the diagnosis of amnestic mild cognitive impairment (aMCI) from patients with Alzheimer's disease (AD) and healthy controls (HCs). 10 IMPACT Strategic Research Centre, Deakin University, Geelong, Victoria, Australia.9 Department of Psychiatry, Medical University of Plovdiv and Technological Center for Emergency Medicine, Plovdiv, Bulgaria.8 Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.7 Angthong Hospital, Ang Thong, Thailand.6 Chao-Phraya-Abhaibhubejhr Hospital, Prachinburi, Thailand.5 Department of Psychiatry, Faculty of Medicine, Thammasat University, Prathumthani, Thailand.4 Department of Clinical Epidemiology, Faculty of Medicine, Thammasat University, Prathumthani, Thailand.1 Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand, 2 Cognitive Fitness Research Group, Chulalongkorn University, Bangkok, Thailand, 3 Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.Global scales for cognitive screening in Parkinson's disease: Critique and recommendations. Skorvanek M, Goldman JG, Jahanshahi M, Marras C, Rektorova I, Schmand B, et al. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. Pedersen KF, Larsen JP, Tysnes OB, Alves G. Predicting motor decline and disability in Parkinson disease: a systematic review. Cognitive and behavioral disorders in Parkinson’s disease: an update. Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: a meta-analysis. Further studies are nevertheless needed that confirm its diagnostic values against a measure other than the MMSE.Ĭognitive screening Montreal Cognitive Assessment Neuropsychology Parkinson’s disease.īaiano C, Barone P, Trojano L, Santangelo G. The Italian MoCA is a valid and diagnostically sound screener for global cognitive inefficiency in non-demented PD patients. A MoCA score adjusted for age and education according to the most recent normative dataset and < 19.015 is herewith suggested as indexing cognitive impairment in this population (AUC =. Both raw and adjusted MoCA scores proved to be highly accurate to the aim of identifying patients with MMSE-confirmed cognitive dysfunctions. 001) and the vast majority of second-level cognitive measures (ps <. The MoCA was associated with both PD-CRS scores (p <. Diagnostics were tested via receiver-operating characteristics analyses against a below-cut-off MMSE score. Construct validity was assessed against both the PD-CRS and the second-level cognitive battery. A subsample (N = 60) also underwent a second-level cognitive battery encompassing measures of attention/executive functioning, language, memory, praxis and visuo-spatial abilities. This study aimed at: (1) assessing, in an Italian cohort of non-demented Parkinson's disease (PD) patients, the construct validity of the Montreal Cognitive Assessment (MoCA) against both first- and second-level cognitive measures (2) delivering an exhaustive and updated evaluation of its diagnostic properties.Ī retrospective cohort of N = 237 non-demented PD patients having been administered the MoCA was addressed, of whom N = 169 further underwent the Mini-Mental State Examination (MMSE) and N = 68 the Parkinson's Disease Cognitive Rating Scale (PD-CRS).

The montreal cognitive assessment moca